107 related articles for article (PubMed ID: 24602684)
1. [Management of the cardiovascular complications of treatment in thoracic oncology].
Ederhy S; Hollebecque A; Haddour N; Massard C; Fleury G; Ferte C; Adavane S; Besse B; Boccara F; Soria JC; Cohen A
Rev Mal Respir; 2014 Feb; 31(2):173-80. PubMed ID: 24602684
[TBL] [Abstract][Full Text] [Related]
2. Cardiac complications and manifestations of chemotherapy for cancer.
Khawaja MZ; Cafferkey C; Rajani R; Redwood S; Cunningham D
Heart; 2014 Jul; 100(14):1133-40. PubMed ID: 24326899
[No Abstract] [Full Text] [Related]
3. [Cardiotoxicity of chemotherapies].
Castel M; Despas F; Modesto A; Gales C; Honton B; Galinier M; Senard JM; Pathak A
Presse Med; 2013 Jan; 42(1):26-39. PubMed ID: 22727981
[TBL] [Abstract][Full Text] [Related]
4. Cancer drugs and the heart: importance and management.
Suter TM; Ewer MS
Eur Heart J; 2013 Apr; 34(15):1102-11. PubMed ID: 22789916
[TBL] [Abstract][Full Text] [Related]
5. Re: Therapy Insight: anthracyclines and trastuzumab--the optimal management of cardiotoxic side effects.
Magné N; Chargari C
Nat Clin Pract Oncol; 2008 Nov; 5(11):E1. PubMed ID: 18957967
[No Abstract] [Full Text] [Related]
6. Cardiovascular effects of treatment with taxanes.
Peroukides S; Alexopoulos A; Kalofonos H; Papadaki H
J Cardiovasc Med (Hagerstown); 2012 May; 13(5):319-24. PubMed ID: 22476001
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemotherapy is essential for conservative surgery of Askin tumors.
Veronesi G; Spaggiari L; De Pas T; Solli PG; De Braud F; Catalano GP; Curigliano G; Leo F; Pastorino U
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):428-9. PubMed ID: 12579122
[No Abstract] [Full Text] [Related]
8. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
Yeh ET; Tong AT; Lenihan DJ; Yusuf SW; Swafford J; Champion C; Durand JB; Gibbs H; Zafarmand AA; Ewer MS
Circulation; 2004 Jun; 109(25):3122-31. PubMed ID: 15226229
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular adverse effects of targeted antiangiogenic drugs: mechanisms and management.
Sundararajan S; Kumar A; Poongkunran M; Kannan A; Vogelzang NJ
Future Oncol; 2016; 12(8):1067-80. PubMed ID: 26901457
[TBL] [Abstract][Full Text] [Related]
10. Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy.
Khakoo AY; Yeh ET
Nat Clin Pract Oncol; 2008 Nov; 5(11):655-67. PubMed ID: 18797437
[TBL] [Abstract][Full Text] [Related]
11. Predicting and preventing the cardiotoxicity of cancer therapy.
Anderson B; Sawyer DB
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):1023-33. PubMed ID: 18666852
[TBL] [Abstract][Full Text] [Related]
12. Re: Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial.
Musallam KM; Taher AT
J Natl Cancer Inst; 2009 Dec; 101(23):1657; author reply 1657-8. PubMed ID: 19858426
[No Abstract] [Full Text] [Related]
13. Cardiovascular effects of systemic cancer treatment.
Senkus E; Jassem J
Cancer Treat Rev; 2011 Jun; 37(4):300-11. PubMed ID: 21126826
[TBL] [Abstract][Full Text] [Related]
14. [Drug-induced cardiotoxicity].
Nishii M; Izumi T
Nihon Rinsho; 2012 Aug; 70 Suppl 6():97-105. PubMed ID: 23156493
[No Abstract] [Full Text] [Related]
15. Early breast cancer therapy and cardiovascular injury.
Steinherz L
J Am Coll Cardiol; 2008 Mar; 51(12):1235; author reply 1235. PubMed ID: 18355667
[No Abstract] [Full Text] [Related]
16. [Anti-angiogenic factors in thoracic oncology: successes, failures and prospects].
Marco S; Tomasini P; Greillier L; Barlesi F
Rev Mal Respir; 2011 Dec; 28(10):1216-29. PubMed ID: 22152931
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and clinical course of cardiovascular toxicity of cancer treatment II. Hematology
Breccia M; Carver JR; Szmit S; Jurczak W; Salvatorelli E; Minotti G
Semin Oncol; 2019 Dec; 46(6):403-407. PubMed ID: 31748121
[TBL] [Abstract][Full Text] [Related]
18. Cardiotoxicity debated for anthracyclines and trastuzumab in breast cancer.
Brower V
J Natl Cancer Inst; 2013 Jun; 105(12):835-6. PubMed ID: 23733910
[No Abstract] [Full Text] [Related]
19. [Drug prescription protocol to improve prescription safety in thoracic oncology].
Pujol JL; Beaupin C; Quantin X; Savelli K; Odoul M; Godard P
Rev Mal Respir; 1999 Feb; 16(1):107-9. PubMed ID: 10091271
[No Abstract] [Full Text] [Related]
20. Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide.
Feola M; Garrone O; Occelli M; Francini A; Biggi A; Visconti G; Albrile F; Bobbio M; Merlano M
Int J Cardiol; 2011 Apr; 148(2):194-8. PubMed ID: 19945181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
